INOTEK PHARMACEUTICALS CORP's ticker is ITEK and the CUSIP is 45780V102. A total of 81 filers reported holding INOTEK PHARMACEUTICALS CORP in Q3 2016. The put-call ratio across all filers is 6.55 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $98,000 | +237.9% | 37,665 | +132.6% | 0.00% | – |
| Q3 2017 | $29,000 | -72.1% | 16,190 | -70.3% | 0.00% | – |
| Q2 2017 | $104,000 | -34.2% | 54,424 | -31.3% | 0.00% | – |
| Q1 2017 | $158,000 | -63.6% | 79,260 | +11.2% | 0.00% | – |
| Q4 2016 | $434,000 | +244.4% | 71,277 | +321.5% | 0.00% | – |
| Q2 2016 | $126,000 | -59.1% | 16,909 | -48.3% | 0.00% | – |
| Q3 2015 | $308,000 | – | 32,719 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Devon Park Associates, LLC | 3,243,709 | $36,751,000 | 100.00% |
| RHO CAPITAL PARTNERS INC | 2,627,790 | $29,773,000 | 10.24% |
| Private Capital Advisors, Inc. | 341,000 | $3,864,000 | 1.67% |
| NEXTHERA CAPITAL LP | 42,000 | $476,000 | 0.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 360,000 | $4,079,000 | 0.60% |
| SENZAR ASSET MANAGEMENT, LLC | 309,600 | $3,507,768,000 | 0.39% |
| Graticule Asia Macro Advisors LLC | 148,000 | $1,676,000 | 0.27% |
| FT Options LLC | 26,421 | $299,000 | 0.22% |
| EAM Investors, LLC | 128,911 | $1,461,000 | 0.19% |
| Tekla Capital Management LLC | 425,000 | $4,815,000 | 0.18% |